Processa Pharmaceuticals, Inc.
Historical 13F Holders
Symbol
PCSA
CUSIP
74275C304
All holders as of
Q1 2025
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2025 Q1
10
171 k
$63.2 k
$0
2024 Q4
9
98.9 k
$87.5 k
$0
2024 Q3
9
48.6 k
$66.5 k
$0
2024 Q2
10
45.0 k
$101 k
$0
2024 Q1
12
106 k
$251 k
$0